News
Praxa Sense secures investment round: Certified remote patient monitoring within reach
Delft, July 2023 – The Dutch MedTech startup Praxa Sense, a company with leading solutions in remote patient monitoring, successfully secured an investment round to enter the commercialisation phase. This round is led by busin
15-years LS@W by Chrétien Herben and Math Kohnen
LifeSciences@Work (LS@W) started in 2008, and now in 2023, it proudly celebrates its 15th anniversary. To mark this festive occasion, the special edition of the Health~Holland Update is devoted to the successes of LS@W throughout the years.
Financial Times - Europe’s Leading Start-up Hubs 2024
The Financial Times is seeking to rank accelerator and incubator programmes in Europe.
Faculty of Impact-call on Life Sciences & health
The Faculty of Impact program is aimed at researchers who want to achieve impact with their research and are interested in setting up their own company.
The deadline for the Venture Challenge Fall 2023 edition is approaching fast!
Thursday 13 July at 14:00 CEST the call closes The Venture Challenge is a 10-week programme to develop an initial idea – a breakthrough research result – into a solid business case.
River BioMedics secures seed investment to progress its cardiovascular disease pipeline
Enschede, The Netherlands, 05 July 2023
STENTiT awarded with €12.5M funding from the European Innovation Council (EIC) Accelerator
The EIC funding comprises €2.5M of grants to conduct first clinical trials and up to €10M in follow-up equity investment to extend the trials and work on market introduction.
15 years of LifeSciences@Work event!
15 years of LifeSciences@Work and the Venture Challenge were celebrated last week at Pivot Park. There were multiple panel discussions, led by our amazing host for the day, Eline van Beest.
ExCulture wins Venture Challenge Spring 2023!
The winner of the Venture Challenge was announced today at the Dutch Biotech Event. The proud winner of the 2023 spring edition is ExCulture! The innovative startup ExCulture has developed a proprietary, natural, mixed-culture fermentation bioprocess to produce the world’s most commonly used blood thinner, heparin.
LifeSciences@Work Succes Stories
Special Edition - 15-year anniversary